Lilly to build $2.5B factory in Germany for injectable drugs
The announcement represents the company’s latest move to meet the soaring demand for its medicines for diabetes and weight loss.
John Russell
Articles
Carmel sanitizing device maker 3Oe Scientific files for bankruptcy
The business makes a hand-sanitizing device called Iggy that kills pathogens with ozone-infused water instead of soap or other chemicals.
Lilly’s proposed $1.4B acquisition of Point Biopharma gets investor pushback
Point has a pipeline of clinical and preclinical-stage compounds in development for the treatment of cancer using radiopharmaceutical isotopes that hold the promise of delivering targeted treatments to cancer patients.
Rising hospital CEO pay raises flags
Consumer advocates and other across the country and in central Indiana are saying big executive-compensation packages are ripe for review.
Republic Services to build plastics recycling operation on south side
Republic Services called the development the “nation’s first integrated plastics recycling facility,” designed to address increasing demand from consumers and packaging manufacturers for recycled plastic.
Lilly bracing for demand crush for newly approved obesity drug
The Indianapolis-based drug company is ramping up manufacturing capacity to avoid possible shortages and to meet potentially huge demand in a nation where more than 40% of adults are classified as obese.
FDA approves Lilly’s diabetes drug for weight management
Eli Lilly and Co.’s hot-selling diabetes drug, Mounjaro, will now be sold for a second use, chronic weight management, using a separate brand name, Zepbound.
Community Health sets aside $75M in ‘potential settlement agreement’ with feds, whistleblower
If a settlement is reached, it could end a legal saga that has stretched out for more than nine years, involving nearly 700 filings in the federal court docket.
Lilly posts 3Q loss of $57M, cuts full-year profit guidance
Excluding nonrecurring items, the Indianapolis-based drugmaker posted adjusted earnings of 10 cents a share, beating Zacks consensus estimate of a loss of 11 cents a share.
Syra Health rings Nasdaq opening bell; shares slide to new low
The company was formed only three years ago and went public on Sept. 29 in an initial public offering that raised $5.3 million after expenses.
IU to spend $250M on new life-science institutes in Indy, faculty, labs, research
IU’s newest plans are intended to bolster enrollment and establish Indiana University Indianapolis as one of the country’s premier urban research universities.
Eskenazi Hospital to expand therapy dog program with $1M gift
At Eskenazi and other hospitals around central Indiana, therapy dogs are seen as part of the health care team—furry healing agents who bring smiles to patients, and perhaps even more.
Higher costs of wages, supplies shrink Community Health’s operating income
Community Health Network said Thursday that operating income fell 38% in the first nine months of the year as higher expenses ate into the bottom line.
IU Health Foundation launches $200M fundraising campaign
Indiana University Health Foundation, the fundraising arm of IU Health’s adult hospitals, is launching the campaign with the ambitious goal of making Indiana one of the healthiest states in the country.
Life science boosters hail Indiana’s designation as federal technology hub
The federal designation marks Indiana as a hub for biologics manufacturing. Biologics are medicines derived from biological sources and include vaccines, monoclonal antibodies, and immune modulators.
Woman to plead guilty of leading conspiracy that defrauded Lilly of more than $600K
According to the petition Courtney Anguiano knowingly conspired with seven other people to submit 189 false and fraudulent post-transaction reimbursement requests under three different Eli Lilly and Co. savings card programs.
Point Biopharma insiders to reap millions from Lilly deal
Top executives and directors of Indianapolis-based Point Biopharma Global Inc. could rake in an eye-popping $212 million from their deal to sell the company to drugmaker Eli Lilly and Co.
State’s newest public company faces hurdles
Syra Health Corp., a Carmel-based health care services company, raised $5.3 million after expenses in its initial public offering. But it faces a slew of challenges, from winning new customers to launching products and services quickly to stem losses.
Nearly two-thirds of serious mental health needs unmet in Marion County, report says
The latest report, called “Community Mental Health Needs Assessment Report for Marion County,” estimates that nearly 26,000 residents who needed treatment for a mental illness in 2022 did not receive it.
Federal government repaying Indiana hospitals $222M for improper reimbursement cuts
After a bruising, five-year fight that went all the way to the U.S. Supreme Court, hospitals across Indiana and the nation are in line for a huge payday.